Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
About this item
Full title
Author / Creator
Agnelli, Giancarlo , Becattini, Cecilia , Meyer, Guy , Muñoz, Andres , Huisman, Menno V , Connors, Jean M , Cohen, Alexander , Bauersachs, Rupert , Brenner, Benjamin , Torbicki, Adam , Sueiro, Maria R , Lambert, Catherine , Gussoni, Gualberto , Campanini, Mauro , Fontanella, Andrea , Vescovo, Giorgio , Verso, Melina and Caravaggio Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a randomized trial, oral apixaban was noninferior to a low-molecular-weight heparin, dalteparin, in preventing recurrent venous thromboembolism at 6 months in patients with cancer. The use of apixaban was not associated with a higher risk of major bleeding than dalteparin, even in patients with gastrointestinal cancer.
Alternative Titles
Full title
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Authors, Artists and Contributors
Author / Creator
Becattini, Cecilia
Meyer, Guy
Muñoz, Andres
Huisman, Menno V
Connors, Jean M
Cohen, Alexander
Bauersachs, Rupert
Brenner, Benjamin
Torbicki, Adam
Sueiro, Maria R
Lambert, Catherine
Gussoni, Gualberto
Campanini, Mauro
Fontanella, Andrea
Vescovo, Giorgio
Verso, Melina
Caravaggio Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2393644806
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2393644806
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1915103
